Transgenesis enables the elucidation of gene function; however, constant transgene expression is not always desired. The tetracycline responsive system was devised to turn on and off transgene expression at will. It has two components: a doxycycline controlled transactivator (TA) and an inducible expression cassette. Integration of these transgenes requires two transfection steps usually accomplished by sequential random integration. Unfortunately, random integration can be problematic due to chromatin position effects, integration of variable transgene units and mutation at the integration site. Therefore, targeted transgenesis and knockin were developed to target the TA and the inducible expression cassette to a specific location, but these approaches can be costly in time, labor and money. Here we describe a one-step Cre-mediated knockin system in mouse embryonic stem (ES) cells that positions the TA and inducible expression cassette to a single location. Using this system, we show doxycycline-dependent regulation of eGFP at the DNA topoisomerase 3β (Top3β) promoter. Since Cre-mediated recombination is used in lieu of gene targeting, this system is fast and efficient. Keywords knockin; gene targeting; inducible expression, Cre/loxP Constant transgene expression is not always desirable; therefore, the tetracycline responsive system was developed to regulate transgene expression. It is based on the Tn10-specific tetracycline-resistance operon found in Escherichia coli (Hillen and Berens, 1994) and has two basic components. One component is a tetracycline-controlled transactivator (TA) (Gossen et al., 1995) and the other component is a TA-inducible expression cassette with a nonfunctional promoter. This promoter contains a series of eight tet operator (tetO) sequences immediately upstream of a minimal CMV promoter, called tetO-mCMV. Transcription is induced after the TA binds to the tetO sequences. The investigator controls transcription with doxycycline (dox), a tetracycline derivative that binds the TA to regulate activity. Thus, the investigator controls transgene expression with dox.Both the TA and the inducible expression cassette must be integrated into cells by sequential rounds of random integration, targeted transgenesis or knockin. Random transgene integration can be problematic due to variable transgene copy number (Sandgren et al., 1991), epigenetic promoter silencing (al-Shawi et al., 1990), and mutagenesis (Covarrubias et al., 1986). To avoid these problems, targeted transgenesis (Jasin et al., 1996;Vivian et al., 1999) and knockin (Hanks et al., 1995;Shin et al., 1999) were developed. For targeted